OrbiMed's Pharmaceutical Portfolio

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

OnCusp Therapeutics is a biopharmaceutical company turning cutting-edge research assets into innovative oncology treatments.

Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases.

Corteria Pharmaceuticals develops first-in-class drugs in heart failure subpopulations.

BlossomHill Therapeutics is a biopharmaceutical company focusing on oncology and autoimmune disorders.

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Invivyd develops antibodies to transcend the limitations of the human immune system and fight against viral infections.

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

TELA Bio is a life science company that specializes in soft tissue reconstruction.

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Rhythm is a biopharmaceutical company focused on developing and commercializing peptide therapeutics

Forte Biosciences is a biotechnology company that focuses on dermatology.

Sirius Therapeutics is an innovative biotechnology company that focuses on RNAi therapies for cardiovascular diseases.

89bio is a biopharmaceutical company that develops clinical-stage therapies for liver and cardiometabolic diseases.

Ottimo Pharma develops innovative cancer therapies using PD1-VEGFR2 antibodies.

Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.